Clinical Trial Update: Quinacrine-Capecitabine Combinatorial Therapy for Advanced Stage Colorectal Adenocarcinoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on quinacrine-capecitabine combination for advanced colorectal adenocarcinoma; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Adenocarcinoma

Drugs mentioned

• Quinacrine-capecitabine combination

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Colorectal Adenocarcinoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2021-03-25